Daehan New Pharm Co., Ltd. (KOSDAQ: 054670)

Daehan New Pharm Revenue

Daehan New Pharm had revenue of 14.55B KRW in the quarter ending September 30, 2013, with 12.73% growth. This brings the company's revenue in the last twelve months to 54.48B, up 19.23% year-over-year. In the year 2012, Daehan New Pharm had annual revenue of 48.01B with 7.83% growth.

• Revenue (ttm): 54.48B
• Revenue Growth: +19.23%
• P/S Ratio: 1.75
• Revenue / Employee: 238.93M
• Employees: 228
• Market Cap: 95.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2012	48.01B	3.49B	7.83%
Dec 31, 2011	44.52B	-5.12B	-10.32%
Dec 31, 2010	49.65B	9.24B	22.88%
Dec 31, 2009	40.40B	6.42B	18.91%
Dec 31, 2008	33.98B	-19.80B	-36.82%